Rep. Doggett: Big Price, Modest COVID-19 Drug
June 30, 2020
June 30, 2020
WASHINGTON, June 30 -- Rep. Lloyd Doggett, D-Texas, issued the following statement:
U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, released the following statement regarding Gilead's announcement this morning that it will charge about $3,120 for a treatment course of remdesivir per patient with commercial insurance in the United States.
* * *
"An outrageous price for a very modest drug, which taxpayer f . . .
U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, released the following statement regarding Gilead's announcement this morning that it will charge about $3,120 for a treatment course of remdesivir per patient with commercial insurance in the United States.
* * *
"An outrageous price for a very modest drug, which taxpayer f . . .